XML 32 R20.htm IDEA: XBRL DOCUMENT

SHAREHOLDERS' EQUITY (Tables)

6 Months Ended

Feb. 28, 2023

Shares Outstanding

Shares of Company common stock outstanding for the three and six months ended February 28, 2023 and 2022 were as follows:


	Three Months Ended February 28,		Six Months Ended February 28,
	2023	2022	2023	2022
Common stock outstanding, beginning of period	20,313,755	20,168,796	20,260,070	20,141,521
Common stock repurchased during the period *	(408,685)	—	(408,685)	—
Common stock issued during the period	25,553	12,988	79,238	40,263
Common stock outstanding, end of period	19,930,623	20,181,784	19,930,623	20,181,784

*Common stock repurchased per the ASR Agreement, as discussed in further detail in this footnote, below.

Schedule of Dividends Payable

Dividends

The Company’s Board of Directors declared cash dividends during the fiscal years 2023 and 2022. The details of dividends paid are in the following tables:


(in thousands, except dividend per share)	Fiscal Year 2023

Record Date	Distribution Date	Number of Shares Outstanding on Record Date	Dividend per Share		Total Amount
10/31/2022	11/07/2022	20,299	$	0.06	$	1,218
1/30/2023	2/06/2023	19,924	$	0.06	1,195


Total					$	2,413


(in thousands, except dividend per share)	Fiscal Year 2022

Record Date	Distribution Date	Number of Shares Outstanding on Record Date	Dividend per Share		Total Amount
10/25/2021	11/01/2021	20,148	$	0.06	$	1,209
1/31/2022	2/07/2022	20,178	$	0.06	1,211
4/25/2022	5/02/2022	20,207	$	0.06	1,212
7/25/2022	8/01/2022	20,239	$	0.06	1,214
Total					$	4,846

Share-based Payment Arrangement, Option, Activity

The following tables summarize information about stock options:


(in thousands, except per share and weighted-average amounts)
Transactions During The Six Months Ended February 28, 2023	Number of Options	Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Life
Outstanding, August 31, 2022	1,245	$	28.61	6.14 years
Granted	434	43.82
Exercised	(77)	14.94
Canceled/Forfeited	(26)	40.48
Outstanding, February 28, 2023	1,576	$	33.27	6.85 years
Vested and Exercisable, February 28, 2023	766	$	21.76	4.69 years
Vested and Expected to Vest, February 28, 2023	1,569	$	33.23	6.84 years

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

The following table summarizes the fair value of the options, including both ISOs and NQSOs, granted during the current fiscal year 2023 and fiscal year 2022:


(in thousands, except prices)	Six Months Ended February 28, 2023			Fiscal Year 2022
Estimated fair value of awards granted	$	9,457		$	4,597
Unvested Forfeiture Rate	0.00		%	1.04		%
Weighted-average grant price	$	43.82		$	42.13
Weighted-average market price	$	43.82		$	42.13
Weighted-average volatility	46.26		%	42.80		%
Weighted-average risk-free rate	4.32		%	1.74		%
Weighted-average dividend yield	0.55		%	0.58		%
Weighted-average expected life	6.59 years			6.59 years

Share-based Payment Arrangement, Option, Exercise Price Range

The exercise prices for the options outstanding at February 28, 2023, ranged from $6.85 to $66.14, and the information relating to these options is as follows:

(in thousands except prices)


Exercise Price				Awards Outstanding				Awards Exercisable
Low		High		Quantity	Weighted -Average Remaining Contractual Life	Weighted-Average Exercise Price		Quantity	Weighted-Average Remaining Contractual Life	Weighted-Average Exercise Price
$	6.85	$	9.77	259	2.27 years	$	8.33	259	2.27 years	$	8.33
$	9.78	$	18.76	174	3.99 years	$	10.10	174	3.99 years	$	10.10
$	18.77	$	33.40	214	6.15 years	$	25.37	147	6.06 years	$	24.62
$	33.41	$	47.63	646	9.15 years	$	42.06	84	7.58 years	$	37.92
$	47.64	$	66.14	283	8.07 years	$	56.27	102	7.68 years	$	58.55
				1,576	6.85 years	$	33.27	766	4.69 years	$	21.76